Search Results - "Arnold, Aer"

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction by Van de Werf, F., Arnold, A. E.

“…STUDY OBJECTIVE--To assess effect of intravenous recombinant tissue type plasminogen activator on size of infarct, left ventricular function, and survival in…”
Get full text

Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction by WILLEMS, J. L, WILLEMS, R. J, WILLEMS, G. M, ARNOLD, A. E. R, VAN DE WERF, F, VERSTRAETE, M

Get full text

Estimated gain in life expectancy : A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction by BOERSMA, H, VAN DER VLUGT, M. J, ARNOLD, A. E. R, DECKERS, J. W, SIMOONS, M. L

“…Currently several modes of reperfusion therapy for acute myocardial infarction are available. Streptokinase, accelerated alteplase and direct angioplasty are…”
Get full text

Impaired glucose metabolism predicts mortality after a myocardial infarction by Bolk, J., van der Ploeg, Tj, Cornel, J.H., Arnold, A.E.R., Sepers, J., Umans, V.A.W.M.

“…Diabetes is a risk factor for increased mortality after a myocardial infarction. Whether this applies for patients with hyperglycemia during the acute phase of…”
Get full text

Educating doctors in the clinical workplace: unraveling the process of teaching and learning in the medical resident as teacher by Busari, J O, Arnold, Aer

“…In recent years, higher medical education has witnessed major changes in the structure and content of postgraduate medical training. Seven professional…”
Get full text

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial by de Bono, D P, Simoons, M L, Tijssen, J, Arnold, A E, Betriu, A, Burgersdijk, C, López Bescos, L, Mueller, E, Pfisterer, M, Van de Werf, F

“…OBJECTIVE--To determine whether concomitant treatment with intravenous heparin affects coronary patency and outcome in patients treated with alteplase…”
Get full text

Variability in treatment advice for elderly patients with aortic stenosis: a nationwide survey in the Netherlands by Bouma, B J, van der Meulen, J H P, van den Brink, R B A, Arnold, A E R, Smidts, A, Teunter, L H, Lie, K I, Tijssen, J G P

“…OBJECTIVE To determine how the decisions of Dutch cardiologists on surgical treatment for aortic stenosis were influenced by the patient's age, cardiac signs…”
Get full text

Validity of conjoint analysis to study clinical decision making in elderly patients with aortic stenosis by Bouma, B.J., van der Meulen, J.H.P., van den Brink, R.B.A., Smidts, A., Cheriex, E.C., Hamer, H.P., Arnold, A.E.R., Zwinderman, A.H., Lie, K.I., Tijssen, J.G.P.

“…Written case simulations are increasingly being used to investigate clinical decision making. Our study was designed to determine the validity of written case…”
Get full text

A man with diabetes and heart failure by Nijveldt, Robin, Serné, Erik H, Sepers, Jan M, Maassen, J Antonie, Cornel, Jan Hein, Arnold, Alf ER

“…An estimated 1.3% of all diabetic patients have MIDD.2 The disease shows maternal inheritance, in agreement with a mitochondrial point mutation.1 Most patients…”
Get full text

Tailored thrombolytic therapy : a perspective by SIMOONS, M. L, ARNOLD, A. E. R

“…In contrast with current standard regimens, it seems more appropriate to tailor thrombolytic therapy to individual patient characteristics. A proposed model…”
Get full text

Expected infarct size without thrombolysis', a concept that predicts immediate and long-term benefit from thrombolysis for evolving myocardial infarction by Arnold, A. E. R., Simoons, M. L.

“…Background Thrombolytic therapy should only be used when expected benefits outweigh the risks. In order to obtain a precise estimation of prognosis, with and…”
Get full text

Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase : correlation with concomitant heparin, coronary artery patency, and recurrent ischemia by RAPOLD, H. J, DE BONO, D, ARNOLD, A. E. R, ARNOUT, J, DE COCK, F, COLLEN, D, VERSTRAETE, M

Get full text

Selection of reperfusion therapy for individual patients with evolving myocardial infarction

Get full text

Coronary-artery bypass surgery with internal-thoracic-artery grafts by Koorevaar, M, Arnold, A E, Cornel, J H

Get full text

Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris by de Maat, M P, Arnold, A E, van Buuren, S, Wilson, J H, Kluft, C

“…Elevated plasma fibrinogen levels are associated with an increased risk for cardiac events. Ticlopidine is a drug that inhibits the ADP-induced aggregation of…”
Get more information

Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction : one-year follow-up by ARNOLD, A. E. R, SIMOONS, M. L, VAN DE WERF, F, DE BONO, D. P, LUBSEN, J, TIJSSEN, J. G. P, SERRUYS, P. W, VERSTRAETE, M

Get full text

Nifedipine in severe aortic regurgitation by Klein, L J, Reichert, C L, Arnold, A E

Get full text

Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk by Arnold, A E, Simoons, M L

“…Thrombolytic therapy is a major step forward in the treatment of acute myocardial infarction and results in substantial reduction of mortality. However, in…”
Get more information

Emergency coronary angioplasty in refractory unstable angina by de Feyter, P J, Serruys, P W, van den Brand, M, Balakumaran, K, Mochtar, B, Soward, A L, Arnold, A E, Hugenholtz, P G

“…We performed percutaneous transluminal coronary angioplasty as an emergency procedure in 60 patients with unstable angina pectoris that was refractory to…”
Get more information

Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate by Verstraete, Marc, Arnold, Alfred E.R., Brower, Ronald W., Collen, Désiré, de Bono, David P., De Zwaan, Chris, Erbel, Rainer, Hillis, W.Stuart, Lennane, R.John, Lubsen, Jacobus, Mathey, Detlef, Reid, Douglas S., Rutsch, Wolfgang, Schartl, Michael, Schofer, Joachim, Serruys, Patrick W., Simoons, Maarten L., Uebis, Rainer, Vahanian, Alec, Verheugt, Freek W.A., von Essen, Rainer

“…An intravenous infusion of 40 mg of recombinant tissue-type plasminogen activator (rt-PA) was given intravenously over 90 minutes to 123 patients with acute…”
Get full text